Derma Sciences is a global medical technology company that develops, manufactures, and markets wound care and specialty surgical products. The company is publicly traded on the Nasdaq stock exchange, and its shares are owned by a diverse group of individual and institutional investors. As a publicly traded company, the ownership of Derma Sciences is constantly changing as shares are bought and sold on the stock market.